Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[89Zr]Zr-DFO-TATE
- Development stage
- Preclinical
- Lead developer
- University of Tennessee
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals, Peptides
- Administration
- Intravenous
01
Overview
[89Zr]Zr-DFO-TATE is a novel radiopharmaceutical consisting of the somatostatin analog octreotate (TATE) conjugated with the chelator deferoxamine (DFO) and radiolabeled with the positron-emitting radionuclide zirconium-89 (89Zr). It is designed as a positron emission tomography (PET) imaging agent targeting somatostatin receptors (SSTR), which are overexpressed in neuroendocrine tumors (NETs). Due to the relatively long physical half-life of zirconium-89 (3.27 days), [89Zr]Zr-DFO-TATE is being evaluated for predictive dosimetry and treatment planning in patients undergoing peptide receptor radionuclide therapy (PRRT) with agents like [177Lu]Lu-DOTA-TATE (Lutathera).
- Other names
- 89Zr-DFO-octreotate89Zr-DFO-TATE[89Zr]Zr-DFO-octreotate
02
Targets
SSTR2 (Somatostatin receptor type 2)
Beyond the preview
Go deeper on [89Zr]Zr-DFO-TATE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [89Zr]Zr-DFO-TATE.